Skin and Soft Tissue Substitutes
Summary
This policy revision expands the list of skin and soft tissue substitutes classified as unproven and not medically necessary, adding 20+ product names and their associated HCPCS codes (A2040-A2045, Q4418-Q4440). It also establishes specific coverage criteria for EPIFIX/GRAFIX (limited to diabetic foot ulcers meeting strict requirements) and TransCyte (limited to thermal burn wounds). Billing teams must update claim denial logic and prior authorization rules to reflect these new coverage restrictions effective August 1, 2026.
Get alerts when payers change rules like this one
We check UnitedHealthcare and other payers every day and email you when a change matches your specialty and state.